Back

Extended normothermic machine perfusion preserves viability and tissue integrity of ex vivo human intestine segments

Urbina, P. A. M.; Choi, S. R.; Cheung, D. C.; Egbert, L. K.; Garcia-Neuer, M. I.; Yu, S.; Rehman, N. S.; Hanks, D. G.; Le, T.-A.; Alabay, H. H.; McHugh, K. E.; Hamdan, F. H.; Naik, N.; Faubion, W. A.; Brady, J. T.; Ceylan, H.; Bose, S.

2026-09-18 bioengineering
10.64898/2026.09.17.752436 bioRxiv
Show abstract

Human intestinal diseases, including inflammatory bowel disease (IBD), are difficult to model because existing animal and in vitro systems do not capture the integrated vascular, immune, and metabolic complexity of the intestine. Here, we establish a custom normothermic machine perfusion platform that maintains surgically resected human intestinal tissue for up to 72 hours under near-physiological conditions. Discarded specimens from patients with nonmalignant intestinal diseases, including IBD and diverticulitis, were continuously perfused at 37{degrees}C with real-time hemodynamic and metabolic monitoring. Perfusion preserved tissue viability, mucosal architecture, epithelial integrity, oxygen consumption, metabolic activity, and vascular patency. Daily perfusate sampling enabled longitudinal profiling and experimental modulation of inflammatory mediators, revealing patient-specific immune states. This long-duration platform bridges reductionist in vitro models and clinical disease, enabling mechanistic studies of intestinal inflammation and future testing of personalized therapies in intact patient-derived tissue.

Matching journals

The top 11 journals account for 50% of the predicted probability mass.

50% of probability mass above

"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.